Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pegunigalsidase alfa, a novel PEGylated enzyme replacement therapy for Fabry disease, provides sustained plasma concentrations and favorable pharmacodynamics: A 1-year Phase 1/2 clinical trial.
Schiffmann R, Goker-Alpan O, Holida M, Giraldo P, Barisoni L, Colvin RB, Jennette CJ, Maegawa G, Boyadjiev SA, Gonzalez D, Nicholls K, Tuffaha A, Atta MG, Rup B, Charney MR, Paz A, Szlaifer M, Alon S, Brill-Almon E, Chertkoff R, Hughes D. Schiffmann R, et al. Among authors: atta mg. J Inherit Metab Dis. 2019 May;42(3):534-544. doi: 10.1002/jimd.12080. Epub 2019 Apr 8. J Inherit Metab Dis. 2019. PMID: 30834538 Clinical Trial.
Therapeutic advances in Fabry disease: The future awaits.
Kant S, Atta MG. Kant S, et al. Among authors: atta mg. Biomed Pharmacother. 2020 Nov;131:110779. doi: 10.1016/j.biopha.2020.110779. Epub 2020 Sep 23. Biomed Pharmacother. 2020. PMID: 33152937 Free article. Review.
Pharmacotherapeutic options for kidney disease in HIV positive patients.
Tariq A, Kim H, Abbas H, Lucas GM, Atta MG. Tariq A, et al. Among authors: atta mg. Expert Opin Pharmacother. 2021 Jan;22(1):69-82. doi: 10.1080/14656566.2020.1817383. Epub 2020 Sep 21. Expert Opin Pharmacother. 2021. PMID: 32955946 Free PMC article. Review.
Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals.
Lucas GM, Jing Y, Sulkowski M, Abraham AG, Estrella MM, Atta MG, Fine DM, Klein MB, Silverberg MJ, Gill MJ, Moore RD, Gebo KA, Sterling TR, Butt AA; NA-ACCORD of the IeDEA. Lucas GM, et al. Among authors: atta mg. J Infect Dis. 2013 Oct 15;208(8):1240-9. doi: 10.1093/infdis/jit373. Epub 2013 Jul 31. J Infect Dis. 2013. PMID: 23904290 Free PMC article.
Cross-Sectional and Longitudinal Performance of Creatinine- and Cystatin C-Based Estimating Equations Relative to Exogenously Measured Glomerular Filtration Rate in HIV-Positive and HIV-Negative Persons.
Lucas GM, Atta MG, Zook K, Vaidya D, Tao X, Maier P, Schwartz GJ. Lucas GM, et al. Among authors: atta mg. J Acquir Immune Defic Syndr. 2020 Dec 1;85(4):e58-e66. doi: 10.1097/QAI.0000000000002471. J Acquir Immune Defic Syndr. 2020. PMID: 33136753 Free PMC article.
130 results